Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

Bristol-Myers Squibb has a market cap or net worth of $84.14B. The enterprise value is CHF155.61B.

Bristol-Myers Squibb has 2,034,763,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bristol-Myers Squibb’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is 8.83%.

The current PE Ratio of Bristol-Myers Squibb is -12.81. Bristol-Myers Squibb’s PEG ratio is 0.06.

In the last 12 months, Bristol-Myers Squibb had revenue of 48.30B and earned -8.95B in profits. Earnings per share was -4.41.

In the last 12 months, operating cash flow was 14.31B and capital expenditures -1.22B, giving a free cash flow of 13.09B billion.

Bristol-Myers Squibb pays an annual dividend of CHF0.513, resulting in a dividend yield of 4.92%

Bristol-Myers Squibb upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Bristol-Myers Squibb as a current ratio of 1.25, with Debt / Equity ratio of 294.66%

In the past 12 months, Bristol-Myers Squibb has paid 554.00M in taxes.

Bristol-Myers Squibb EV to EBITDA ratio is 48.31, with an EV/FCF ratio of 11.15.

Bristol-Myers Squibb has $11.78B in cash and marketable securities with $51.24B in debt, giving a net cash position of $39.46B billion.

Gross margin is 65.99%, with operating margin of 12.19%, and net profit margin of -18.53%.

The average price target for Bristol-Myers Squibb is $46.53, which is 11.43% higher than the current price. The consensus rating is Hold